Suven Life Sciences Ltd. engages on discovering, developing, and commercializing novel pharmaceutical products which are used in classic therapies. It operates through the following segments: Manufacturing, Services, and Research & Development. The Manufacturing segment consists of bulk drugs and intermediates under contract services products are developed and produced on an exclusive basis. The Services segment consists of collaborative research projects, clinical trials and testing, and analysis services. The Research & Development segment is involved in discovering and developing new chemical entities. The company was founded on March 9, 1989 and is headquartered in Hyderabad, India.